亚硒酸钠对大鼠代谢产物影响的核磁共振研究

本文采用核磁共振(^1H NMR)技术研究了在最高耐受摄入量条件下补充亚硒酸钠对大鼠尿液代谢产物的影响。结果表明,在大鼠尿液中甲酸、乙酸、乳酸、丙氨酸、琥珀酸、甘氨酸、马尿酸、苯丙氨酸、色氨酸等代谢物谱峰信号显著增强,而柠檬酸、肌酸、尿素、尿甘素和氧化三甲胺(TAMO)的谱峰信号则显著降低。乳酸、柠檬酸和琥珀酸是体内三羧酸循环的中间产物,其代谢异常是能量代谢紊乱的标志;马尿酸、苯丙氨酸、丙氨酸的代谢异常与肾小球的滤过和回收功能有关;乙酸和甘氨酸的代谢异常则是肝功能损伤的标志,组织切片的结果也证明大鼠的肝和肾已经发生损伤,与^1H NMR的结果相一致。采用HPLC检测到补充亚硒酸钠后尿液中8-OHdG(8-hydroxy1-2′-deoxyguansoine)水平显著升高,证明体内氧化损伤的发生。以上结果表明,在最高耐受摄入量条件下补充亚硒酸钠是不安全的,用NMR方法对阐明硒的毒理学分子基础是有效的。     

液相色谱-线性离子阱-静电场轨道阱回旋共振组合质谱法鉴定乙胺嘧啶在大鼠体内的代谢物

研究乙胺嘧啶在大鼠体内的代谢方式与途径.大鼠以5 mg/kg单剂量口服乙胺嘧啶后,在不同时间点分别采集其血液、尿液和粪便样品.采用液相色谱-线性离子阱-静电场轨道阱回旋共振组合质谱仪(LC-LTQ-Orbitrap)检测乙胺嘧啶在大鼠体内的代谢物,结合相关代谢软件,共鉴定出10种代谢产物,主要的代谢途径包括苯环上的羟基化、N-氧化、双氧化、Ⅳ-葡萄糖醛酸结合、甲基化+葡萄糖醛酸结合、羟基化+葡萄糖醛酸结合和Ⅳ-氧化+葡萄糖醛酸结合.除乙胺嘧啶3-N-氧化物已经在大鼠体外代谢研究中被发现外,其余9种代谢产物均首次在大鼠体内发现.根据其精确分子量及多级质谱的碎片特征,对这些代谢产物的化学结构做出推断,并建立乙胺嘧啶在大鼠体内的代谢谱系.研究表明,乙胺嘧啶在大鼠体内的Ⅰ相代谢方式主要是羟基化和N位氧化,Ⅱ相代谢方式主要是甲基化和葡萄糖醛酸结合.     

核磁共振技术结合模式识别对中药马兜铃酸亚急性生化效应的研究

利用核磁共振技术结合模式识别方法,研究了马兜铃酸(AristolochicAcid,AA)的亚急性生化效应.大鼠连续5日腹腔注射马兜铃酸后,不同时间段尿液¹HNMR谱显示与肾小管及肾乳头受损相关的标记物(NMRmarker)浓度有显著变化;铬酸钠、氯化汞、二溴乙胺、盐酸肼和异硫氰酸-α-萘酯,并利用主成分分析法对造成的肝肾损伤模型组、AA组和对照组的大鼠尿液¹HNMR谱解析和分类.¹HNMR谱中各种代谢物的谱峰强度变化及主成分分析结果均显示,马兜铃酸引起的肾损伤与肾小管及肾乳头损伤模型类似,且随给药量的积累,肾损伤范围扩大程度加深,引起肾脏不可逆损伤.该方法可用于中药的毒理学研究.     

超高压液相色谱-飞行时间质谱法对比分析沙丁胺醇在猪尿液和血浆中的代谢产物

采用高分辨质谱及代谢物鉴定软件,系统分析了猪尿液和血浆中沙丁胺醇代谢产物。样品用乙腈沉淀蛋白,经离心过滤后,采用Agilent Plus C18色谱柱,以乙腈和醋酸溶液(含0.2%醋酸)作为流动相进行梯度洗脱,采用高分辨质谱(UHPLC-QTOF MS)±离子模式进行检测,利用软件Agilent MassHunter MetaboliteID与人工相结合分析检测数据。结果表明,经灌胃给药后猪尿液中鉴定出沙丁胺醇原形药和葡糖醛酸化、苯环羟基化、N-氧化、苯环甲氧基化、羟基化脱水共5个代谢产物,其中2个代谢物未见文献报道;而血浆中仅检测原型药物和2个代谢物,包括沙丁胺醇的葡糖醛酸化和N-氧化产物。     

基于1HNMR给药赭石后大鼠尿液的代谢组学分析

基于1H NMR 的代谢组学方法结合多变量数据分析方法(主成分分析和偏最小二乘判别分析)对灌胃给药赭石(2,5和10 g/ kg 体重剂量)的成年 Wistar 大鼠尿液进行分析,并对大鼠给药前1天、给药后1~5天尿液1 H NMR 数据进行单变量比较分析,筛选出赭石的潜在特征代谢物,对赭石引起的代谢变化进行研究,为赭石的科学用药提供依据。结果表明,大鼠体内柠檬酸、牛磺酸、肌酸酐、α-酮戊二酸、琥珀酸、二甲基甘氨酸等代谢物浓度发生明显变化,随给药时间的变化出现恢复趋势,且恢复趋势与给药剂量相关,可作为赭石的潜在特征代谢物。给药2,5和10 g/ kg 体重剂量赭石降低了大鼠机体三羧酸循环能力,影响了能量、肌酸及二甲基甘氨酸的代谢,且10 g/ kg 体重剂量赭石对大鼠肝功能造成一定影响。     

模型毒物急性毒性尿液核磁共振氢谱标记物的二阶段聚类分析

采用现代核磁共振技术,通过分析给药肝、肾损伤模型化合物异硫氰酸α-萘酯(灌胃150 mg/kg体重)和二溴乙胺氢溴酸盐(腹腔注射250 mg/kg体重)24 h内W istar大鼠尿液的1H NMR谱,由尿液中内源性代谢物浓度变化研究了肝、肾模型毒物在大鼠体内的急性毒性。首次利用模式识别技术中的二阶段聚类分析方法解析大鼠尿液1H NMR谱确定了模型化合物尿液1H NMR标记物。结果表明,应用核磁共振和二阶段聚类分析相结合的方法,可提供模型化合物毒性比较清楚的认识。该方法也可用于金属化合物、中药及其它药物的毒性分类和预测研究以及建议各类靶向毒性的NMR标记物。     

大鼠尿液中壬基酚的代谢轮廓

运用代谢组学方法研究了壬基酚对大鼠尿液代谢的影响, 通过高效液相色谱-飞行时间质谱技术建立了大鼠尿样的代谢指纹图谱, 用主成分分析法分析给药组与对照组代谢物指纹图谱的差异, 通过t检验选取潜在的生物标志物及效应标志物, 并结合代谢物数据库检索对其进行鉴定. 结果表明, 壬基酚给药后, 尿液中含量变化显著的成分苯基葡萄糖苷酸、L-高半胱氨酸、3-硝基丙酸、肌酸酐、左旋肉碱及5-羟色胺等构成了大鼠尿液代谢的轮廓, 它们在生物体内的变化可能对生殖系统、免疫系统、神经系统及脂肪的代谢造成一定的影响, 从代谢的角度解释了环境雌激素壬基酚对生物体的危害, 为毒理学研究提供了依据.     

N-乙酰-L-半胱氨酸在咖啡酸修饰碳糊电极上的电催化氧化

研究了N-乙酰-L-半胱氨酸（N-acetyl-L-cysteine,NAC）在咖啡酸（CFA）修饰碳糊电极（CFA/CPE）上的电催化行为。结果表明,NAC在裸碳糊电极（CPE）上的直接电化学氧化过程十分迟缓,而CFA/CPE对NAC的电化学氧化具有良好的催化作用。用循环伏安法（CV）、计时电流法（CA）测定了NAC在CFA/CPE上的电极过程动力学参数。电荷传递系数α=0.79,电催化氧化反应速率常数k=（4.40±0.10）×10^3（mol.L^-1）^-1.s^-1。用微分脉冲伏安法（DPV）测得催化氧化峰电流与NAC浓度在1.0×10^-6～7.5×10^-4mol.L^-1范围内呈良好的线性关系,线性回归方程为Ipa（μA）=4.075c（mmol.L^-1）＋2.671,r=0.9988,检出限为1.7×10^-7mol.L^-1。用该方法对市售药品富露施中的NAC含量进行测定,结果令人满意。     

硫酸氧钒毒性的核磁共振代谢组学方法研究

采用基于核磁共振(NMR)的代谢组学方法,结合生化指标分析及组织病理学检测,研究了具有类胰岛素活性的硫酸氧钒(VOSO4)对Wistar大鼠的毒性作用.通过不同剂量的VOSO4对Wistar大鼠连续灌胃给药16d,收集大鼠的血清和尿液,并采集样品的1H NMR谱进行多变量数据统计分析来辨识其特征代谢物,然后采用TICL(a web Tool for automatic Interpretation of Compound List)方法建立特征代谢物的代谢网络模型,分析受影响的主要代谢途径及其相互关系.研究结果表明:高剂量组(45mg/kg)和低剂量组(15mg/kg)的特征代谢物含量与对照组存在明显的差异;与对照组相比,高剂量和低剂量组血清中乳酸、肌氨酸酐以及牛磺酸等代谢物的含量增加,尿液中氧化三甲胺(TMAO)、肌酐、牛磺酸和甘氨酸等代谢物的含量增加,并呈现显著的剂量依赖关系;给药组中乙酸和琥珀酸的含量都降低.这些结果说明VOSO4可能影响大鼠体内的糖代谢、脂类代谢及肠道菌群代谢等多个代谢系统,高剂量的VOSO4会导致肝脏毒性和肾脏损伤.     

模型毒物急性毒性尿液核磁共振氨谱标记物的二阶段聚类分析

采用现代核磁共振技术，通过分析给药肝、肾损伤模型化合物异硫氰酸α-萘酯（灌胃150mg／kg体重）和二溴乙胺氢溴酸盐（腹腔注射250mg／kg体重）24h内Wistar大鼠尿液的^1H NMR谱，由尿液中内源性代谢物浓度变化研究了肝、肾模型毒物在大鼠体内的急性毒性。首次利用模式识别技术中的二阶段聚类分析方法解析大鼠尿液^1H NMR谱确定了模型化合物尿液^1H NMR标记物。结果表明，应用核磁共振和二阶段聚类分析相结合的方法，可提供模型化合物毒性比较清楚的认识。该方法也可用于金属化合物、中药及其它药物的毒性分类和预测研究以及建议各类靶向毒性的NMR标记物。     

Urinary 2-hydroxy-5-oxoproline,the lactam form of α-ketoglutaramate,is markedly increased in urea cycle disorders

α-Ketoglutaramate (KGM) is the α-keto acid analogue of glutamine, which exists mostly in equilibrium with a lactam form (2-hydroxy-5-oxoproline) under physiological conditions. KGM was identified in human urine and its concentration quantified by gas chromatography/mass spectrometry (GC/MS). The keto acid was shown to be markedly elevated in urine obtained from patients with primary hyperammonemia due to an inherited metabolic defect in any one of the five enzymes of the urea cycle. Increased urinary KGM was also noted in other patients with primary hyperammonemia, including three patients with a defect resulting in lysinuric protein intolerance and one of two patients with a defect in the ornithine transporter I. These findings indicate disturbances in nitrogen metabolism, most probably at the level of glutamine metabolism in primary hyperammonemia diseases. Urinary KGM levels, however, were not well correlated with secondary hyperammonemia in patients with propionic acidemia or methylmalonic acidemia, possibly as a result, in part, of decreased glutamine levels. In conclusion, the GC/MS procedure has the required lower limit of quantification for analysis of urinary KGM, which is markedly increased in urea cycle disorders and other primary hyperammonemic diseases.     

Urinary biomarker and treatment mechanism of Rhizoma Alismatis on hyperlipidemia

Rhizoma Alismatis (RA), a diuretic in Asia and Europe, was found to possess anti‐hyperlipidemic activity. Since the biomarkers and mechanisms of RA in the treatment of hyperlipidemia are inadequate, ultra‐performance liquid chromatography coupled with quadrupole time‐of‐flight synapt high‐definition mass spectrometry and multivariate data analysis were employed to investigate the urinary metabolomics of RA on hyperlipidemic rats induced by high‐fat diet. The metabolic profile of RA‐treated hyperlipidemic group located between control and diet‐induced hyperlipidemic groups. Nineteen metabolites with significant fluctuations were identified as potential biomarkers related to the hyperlipidemia and anti‐hyperlipidemia of RA using partial least‐squares‐discriminate analysis, heatmap analysis and correlation coefficient analysis. The fluctuations of these biomarkers represented disturbances in amino acid metabolism, purine metabolism, pyrimidine metabolism and energy metabolism. After RA treatment, these perturbed metabolites were restored to normal or nearly normal levels. RA can alleviate high‐fat diet‐induced dysfunctions in these metabolic pathways.     

黄芪口服液降低大鼠顺铂毒性作用机制的尿液代谢组学研究

采用基于液相色谱-飞行时间质谱联用(LC-TOF-MS)技术的代谢组学方法,分析大鼠尿液内源性代谢物的变化,研究黄芪口服液(HO)降低大鼠顺铂(CDDP)毒性的作用机制.采用低剂量多次腹腔注射CDDP的方法建立CDDP染毒大鼠模型,并连续给予16天HO.于第18天收集正常对照(Control)组、顺铂模型(CDDP)组和黄芪口服液(HO)组大鼠的24 h尿液, 进行LC-TOF-MS分析,以获取尿液代谢物组数据集,对所得数据进行主成分分析(PCA)和正交偏最小二乘法-判别分析(OPLS-DA)等多元统计分析,以筛选潜在生物标志物.于第20天采集大鼠血清测定肌酐和尿素氮水平.血清指标测定结果表明, HO可以显著降低CDDP染毒大鼠的肌酐和尿素氮水平(p<0.05).PCA得分图显示,3组可分别聚类,HO组位于Control组和CDDP组中间,表明HO可部分改善CDDP所致大鼠尿液代谢产物的异常变化.综合OPLS-DA分析、t检验和倍数变化分析结果,最终共筛选并初步鉴定出35个尿液代谢产物作为HO减毒相关的潜在生物标记物.代谢通路分析结果表明,HO可通过纠正体内氨基酸代谢、能量代谢和核苷酸代谢等通路的紊乱,降低CDDP所致机体毒性.     

Speciation of gadolinium in surface water samples and plants by hydrophilic interaction chromatography hyphenated with inductively coupled plasma mass spectrometry

Hydrophilic interaction chromatography (HILIC) coupled with inductively coupled plasma mass spectrometry (ICP-MS) was optimized for speciation analysis of gadolinium-based contrast agents in environmental samples, in particular surface river waters and plants. Surface water samples from the Teltow channel, near Berlin, were investigated over a distance of 5 km downstream from the influx of a wastewater treatment plant. The total concentration of gadolinium increased significantly from 50 to 990 ng?L^?1 due to the influx of the contrast agents. After complete mixing with the river water, the concentration remained constant over a distance of at least 4 km. Two main substances [Dotarem® (Gd-DOTA) and Gadovist® (Gd-BT-DO3A)] have been identified in the river water using standards. A gadolinium-based contrast agent, possibly Gd-DOTA (Dotarem®), was also detected in water plant samples taken from the Teltow channel. Therefore, uptake of contrast agents [Gadovist® (Gd-BTDO3A), Magnevist® (Gd-DTPA), Omniscan® (Gd-DTPA-BMA), Dotarem® (Gd-DOTA), and Multihance® (Gd-BOPTA)] by plants was investigated in a model experiment using Lepidium sativum (cress plants). HILIC–ICP-MS was used for identification of different contrast agents, and a first approach for quantification using aqueous standard solutions was tested. For speciation analysis, all investigated contrast agents could be extracted from the plant tissues with a recovery of about 54 % for Multihance® (Gd-BOPTA) up to 106 % for Gadovist® (Gd-BT-DO3A). These experiments demonstrate that all contrast agents investigated are transported from the roots to the leaves where the highest content was measured.     

Metabonomics Study of Heart Homogenates from Myocardial Infarction Rats Using Liquid Chromatography/Time of Flight Mass Spectrometry

In this study, a metabonomics analysis of heart homogenates from myocardial ischemic rats was performed by LC–TOF–MS. Hydrophilic interaction chromatography (HILIC) was used to separate the endogenous metabolites in heart homogenates. Partial least squares to latent structure-discriminant analysis (PLS-DA) was used for data analysis. Good separations were observed between the normal and model groups and 15 potential biomarkers were identified. The major disturbed metabolic pathways were purine metabolism, pyrimidine metabolism, urea cycle, and energy metabolism. The results demonstrated that a metabonomics approach based on HILIC-MS was useful for studying metabolic mechanism on target tissue of the myocardial infarction rat.

     

Efficacy of Ficus spp. on renal injury induced by hypercholesterolaemia

The ethanol and hexane extracts of Ficus microcarpa, Ficus religiosa and Ficus mysorensis leaves were evaluated against renal injury induced by hypercholesterolaemia. Phytochemical screening of the investigated plants was undertaken. For the in vivo study, all rats were orally given cholesterol (30?mg?kg?1 body weight, BW) and leaves extract (500?mg?kg?1 BW) five times per week for 9 weeks. Hypercholesterolaemic rats showed significant increases in urea nitrogen and creatinine while serum protein and albumin levels, nitric oxide (NO), Na?-K?-ATPase and phospholipids in kidney tissue were all decreased. Treatment with leaves extract improved kidney function indices (urea nitrogen, creatinine, serum protein and albumin), kidney disorder biochemical parameters (NO, Na?-K?-ATPase and phospholipids), haematological profile (haemoglobin, RBCs and WBCs) and kidney histopathology. In conclusion, Ficus spp. succeeded in improving renal injury induced by hypercholesterolaemia, with the most potent effects seen while using Ficus microcarpa hexane extract.     

Protective effect of Salvia miltiorrhiza extract against renal ischemia-reperfusion-induced injury in rats

The present study investigates the effect of pre-treatment with Salvia miltiorrhiza ethanol extracts (SMEE) on renal function markers, immunity and antioxidant activities in renal ischemia and reperfusion (IR) rats. Wistar rat kidneys were subjected to 60 min of global ischemia at 37 °C followed by 30 min of reperfusion, and were randomly assigned into the sham, IR model and three SMEE-treated groups (n = 8 per group). Results showed that high serum creatinin (Scr), blood urea nitrogen (BUN), interleukin-6 (IL-6), interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-α) and malondialhehyde (MDA) levels, and low antioxidant enzyme activities were observed in IR rats compared to the sham rats. Pre-treatment of Salvia miltiorrhiza ethanol extracts for 20 days prior to IR operation improved renal function, reduced IR induced renal inflammatory and oxidative injury. It is concluded that Salvia miltiorrhiza ethanol extracts could be beneficial in the treatment of renal ischemic injury.     

Metabonomics study of the effects of traditional Chinese medicine formula Ermiaowan on hyperuricemic rats

To explore the global mechanism of Ermiaowan on hyperuricemia regulation, the holistic function of Ermiaowan for hyperuricemia in rats was firstly assessed by the urinary metabonomics method which was based on ultra‐high performance liquid chromatography with electrospray ionization quadrupole time‐of‐flight mass spectrometry. The urinary targeted metabonomics approach combined with the serum biochemical analysis and histological assay was conducted to verify the research result. As a result, the significant differences in metabolic profiles were observed from Ermiaowan‐treated group, model group, and healthy control group by using multivariate statistical approaches. Twenty therapeutic related metabolites were identified in response to the therapeutic effects of Ermiaowan, which were mainly associated with purine metabolism, pyrimidine metabolism, tryptophan metabolism, tricarboxylic acid cycle, and tyrosine metabolism. In addition, the urinary targeted metabonomics study showed that Ermiaowan can better restore the disturbed pathways than Phellodendri cortex and Atractylodis rhizome. The biochemical assay and histopathological assay confirmed that Ermiaowan could significantly reduce uric acid and fibrosis areas of kidney. These results provided new insights into the mechanism of Ermiaowan on hyperuricemia.     

Application of 1H-NMR-based metabolomics for detecting injury induced by long-term microwave exposure in Wistar rats’ urine

There has been growing public concern regarding exposure to microwave fields as a potential human health hazard. This study aimed to identify sensitive biochemical indexes for the detection of injury induced by microwave exposure. Male Wistar rats were exposed to microwaves for 6 min per day, 5 days per week over a period of 1 month at an average power density of 5 mW/cm(2) (specific absorption rate of 2.1 W/kg). Urine specimens were collected over 24 h in metabolic cages at 7 days, 21 days, 2 months, and 6 months after exposure. (1)H NMR spectroscopy data were analyzed using multivariate statistical techniques. Urine metabolic profiles of rats after long-term microwave exposure were significantly differentiated from those of sham-treated controls using principal component analysis or partial least squares discriminant analysis. Significant differences in low molecular weight metabolites (acetate, succinate, citrate, ketoglutarate, glucose, taurine, phenylalanine, tyrosine, and hippurate) were identified in the 5 mW/cm(2) microwave exposure group compared with the sham-treated controls at 7 days, 21 days, and 2 months. Metabolites returned to normal levels by 6 months after exposure. These data indicated that these metabolites were related to the perturbations of energy metabolism particularly in the tricarboxylic acid cycle, and the metabolism of amino acids, monoamines, and choline in urine represent potential indexes for the detection of injury induced by long-term microwave exposure.